Ikarian Capital, LLC Vigil Neuroscience, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 250,000 shares of VIGL stock, worth $582,500. This represents 0.06% of its overall portfolio holdings.
Number of Shares
250,000
Previous 500,000
50.0%
Holding current value
$582,500
Previous $840,000
47.02%
% of portfolio
0.06%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding VIGL
# of Institutions
52Shares Held
29.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$13.6 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$9.82 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$9.35 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$4.58 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$4.05 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $65.9M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...